60 DEGREES PHARMACEUTICALS, INC. (SXTP) Net margin 2022–2025
60 DEGREES PHARMACEUTICALS, INC. (SXTP) net profit margin by fiscal year — reported net income divided by reported revenue.
-732.5%FY2025 · since FY2022: -2769.5% → -732.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -732.5% | +575.5 pp |
| FY2024 | -1308.0% | +177.0 pp |
| FY2023 | -1485.1% | +1284.4 pp |
| FY2022 | -2769.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SXTP financial trends
SXTP RevenueSXTP Net incomeSXTP Gross profitSXTP Gross marginSXTP Operating incomeSXTP Operating marginSXTP Operating cash flowSXTP Free cash flowSXTP Capital expendituresSXTP Return on equitySXTP Stock buybacksSXTP Dividends paidSXTP Total assetsSXTP Total liabilitiesSXTP Shareholders’ equitySXTP overview →